Next 10 |
2024-05-04 21:29:41 ET More on Canopy Growth, Curaleaf, etc. Canopy Growth Stock: Expect A Crash After The High Canopy Growth Set For U.S. Cannabis Markets Tilray Brands, Inc. (TLRY) Q3 2024 Earnings Call Transcript Canopy Growth inks $50M financing deal ...
2024-05-03 06:01:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips For cannabis stock investors, April ended in absolute euphoria. The sector has skyrocketed this week. The rally came on reports that the U.S. Drug Enforcement Agency ( DEA ) is set to ...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...
2024-05-01 12:13:14 ET More on cannabis stocks Canopy Growth Stock: Expect A Crash After The High OMB review of cannabis rescheduling could put measure at risk MSOS: Best Play On U.S. Cannabis Regulations Aurora Cannabis: Improved Financials, Limite...
April 20 marks the day when the consumption of marijuana is celebrated globally, with individuals across the globe smoking the drug around 4:20 p.m. The holiday is popularly known as 4/20 and promotes the consumption of marijuana; historically, April 20 is often the best day for business annually...
2024-05-01 09:00:05 ET Summary Shares of cannabis companies soared after news that the US DEA is considering reclassifying marijuana as a Schedule III drug. Canopy Growth Corporation saw the biggest increase, with CGC stock closing up 78.9%. However, Canopy Growth faces financ...
2024-05-01 08:51:46 ET The White House Office of Management and Budget's review of the DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could scuttle the reform, according to one assessment.... Read the full article on Seeking Alpha ...
2024-04-30 16:25:18 ET Summary The U.S. Drug Enforcement Administration (DEA) is moving marijuana from Schedule I to Schedule III under the Controlled Substances Act, and pending approval from the White House Office of Management and Budget. Rescheduling cannabis would allow U.S. ...
2024-04-30 14:20:00 ET Summary The DEA will reportedly reclassify cannabis as a less dangerous drug, potentially moving it from Schedule I to Schedule III. Cannabis stocks surged after the news, with companies like Tilray, Canopy Growth, and Aurora Cannabis seeing a 20% increase. ...
2024-04-30 14:15:33 ET More on cannabis ETFs MSOS: 4/20 Is Cannabis Day - Significant Implications For Investors MJ: Over Diversified Cannabis ETF, But Still A Solid Pick Why Is The MSOS Cannabis ETF Soaring Again? Rescheduling May Be 'Imminent' DEA to resche...
News, Short Squeeze, Breakout and More Instantly...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injecte...
Cannabis stocks Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis, Inc. (NASDAQ:ACB) and Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading...